CG Oncology, Inc.
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 661.05M | 688.43M | 742.00M | 540.71M | 552.88M |
| Total Receivables | 562.00K | 345.00K | 781.00K | 137.00K | 182.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.42M | 12.41M | 11.43M | 11.23M | 10.80M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 673.03M | 701.19M | 754.21M | 552.08M | 563.86M |
|
|
|||||
| Total Current Assets | 673.03M | 701.19M | 754.21M | 552.08M | 563.86M |
| Net Property, Plant & Equipment | 1.22M | 1.30M | 493.00K | 338.00K | 413.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 27.20M | 25.69M | 94.00K | 53.00K | 53.00K |
| Total Assets | 701.45M | 728.18M | 754.80M | 552.47M | 564.33M |
|
|
|||||
| Total Accounts Payable | 7.13M | 6.73M | 6.52M | 4.08M | 4.49M |
| Total Accrued Expenses | 22.73M | 15.18M | 14.23M | 11.11M | 6.99M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 288.00K | 255.00K | 186.00K | 225.00K | 237.00K |
| Total Finance Division Other Current Liabilities | 241.00K | 481.00K | 436.00K | 221.00K | 131.00K |
| Total Other Current Liabilities | 241.00K | 481.00K | 436.00K | 221.00K | 131.00K |
| Total Current Liabilities | 30.38M | 22.64M | 21.37M | 15.63M | 11.85M |
|
|
|||||
| Total Current Liabilities | 30.38M | 22.64M | 21.37M | 15.63M | 11.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 706.00K | 781.00K | 52.00K | 71.00K | 118.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 31.09M | 23.42M | 21.42M | 15.70M | 11.97M |
|
|
|||||
| Common Stock & APIC | 964.22M | 957.19M | 951.36M | 722.95M | 718.14M |
| Retained Earnings | -293.86M | -252.43M | -217.98M | -186.18M | -165.78M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 670.36M | 704.76M | 733.38M | 536.77M | 552.36M |
|
|
|||||